Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Toxicity of 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate in any of the routes have been distinctly observed. 

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Qualifier:
according to guideline
Guideline:
other:
Principles of method if other than guideline:
Standard acute method
GLP compliance:
not specified
Test type:
standard acute method
Species:
mouse
Strain:
not specified
Sex:
not specified
Route of administration:
oral: unspecified
Vehicle:
not specified
Control animals:
not specified
Sex:
not specified
Dose descriptor:
LD50
Effect level:
5 400 mg/kg bw
Based on:
test mat.
Remarks on result:
other: Details of toxic effects not reported other than lethal dose value
Mortality:
Lethal dose ; 50% kill
Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Oral toxicity (LD50) mouse for 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate was examined at dose concentration of 5400 mg/kg of body weight.This value suggests that the chemical does not exhibit acute toxicity through the oral route.
Executive summary:

Oral toxicity (LD50) mouse for 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate was examined at dose concentration of 5400 mg/kg of body weight.This value suggests that the chemical does not exhibit acute toxicity through the oral route.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
5 400 mg/kg bw
Quality of whole database:
Oral toxicity (LD50) mouse for 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate was examined at dose concentration of 5400 mg/kg of body weight.This value suggests that the chemical does not exhibit acute toxicity through the oral route.

Acute toxicity: via inhalation route

Link to relevant study records
Reference
Endpoint:
acute toxicity: inhalation
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Qualifier:
according to guideline
Guideline:
other:
Principles of method if other than guideline:
standard acute method
GLP compliance:
not specified
Test type:
standard acute method
Species:
rat
Strain:
not specified
Sex:
not specified
Route of administration:
inhalation
Type of inhalation exposure:
not specified
Vehicle:
not specified
Duration of exposure:
4 h
Control animals:
not specified
Sex:
not specified
Dose descriptor:
LCLo
Effect level:
1 010 mg/m³ air
Based on:
test mat.
Exp. duration:
4 h
Remarks on result:
other: Toxic Effects : Lungs, Thorax, or Respiration - acute pulmonary edema Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - weight loss or decreased weight gain
Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The toxicity (LCLo) of biphenyl-2,5-diol was tested in rat by inhalative exposure of 4 hour shows toxic effects as Lungs, Thorax, or Respiration - acute pulmonary edema Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - weight loss or decreased weight gain ; if it reaches the dose concentration of 1010 mg/m3 air.
Executive summary:

The toxicity (LCLo) of biphenyl-2,5-diol was tested in rat by inhalative exposure of 4 hour shows toxic effects as Lungs, Thorax, or Respiration - acute pulmonary edema Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - weight loss or decreased weight gain ; if it reaches the dose concentration of 1010 mg/m3 air.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
discriminating conc.
Value:
1 010 mg/m³ air
Quality of whole database:
The toxicity (LCLo) of biphenyl-2,5-diol was tested in rat by inhalative exposure of 4 hour shows toxic effects as Lungs, Thorax, or Respiration - acute pulmonary edema Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - weight loss or decreased weight gain ; if it reaches the dose concentration of 1010 mg/m3 air.

Acute toxicity: via dermal route

Link to relevant study records
Reference
Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Qualifier:
according to guideline
Guideline:
other:
Principles of method if other than guideline:
Standard acute method
GLP compliance:
not specified
Test type:
standard acute method
Species:
rabbit
Strain:
not specified
Sex:
not specified
Type of coverage:
not specified
Vehicle:
not specified
Control animals:
not specified
Sex:
not specified
Dose descriptor:
LD50
Effect level:
> 5 000 other: mg/kg
Based on:
test mat.
Remarks on result:
other: Details of toxic effects not reported other than lethal dose value
Mortality:
Lethal dose, 50 percent kill
Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Dermal toxicity (LD50) rabbit for 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate was examined at dose concentration of >5000 mg/kg of body weight.This value suggests that the chemical does not exhibit acute toxicity through the dermal route.
Executive summary:

Dermal toxicity (LD50) rabbit for 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate was examined at dose concentration of >5000 mg/kg of body weight.This value suggests that the chemical does not exhibit acute toxicity through the dermal route.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
5 000 mg/kg bw
Quality of whole database:
Dermal toxicity (LD50) rabbit for 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate was examined at dose concentration of >5000 mg/kg of body weight.This value suggests that the chemical does not exhibit acute toxicity through the dermal route.

Additional information

Acute toxicity: oral

Oral toxicity (LD50) mouse for 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate was examined at dose concentration of 5400 mg/kg of body weight.This value suggests that the chemical does not exhibit acute toxicity through the oral route.

Acute toxicity: inhalation

The toxicity (LCLo) of biphenyl-2,5-diol was tested in rat by inhalative exposure of 4 hour shows toxic effects as Lungs, Thorax, or Respiration - acute pulmonary edema Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - weight loss or decreased weight gain ; if it reaches the dose concentration of 1010 mg/m3 air.

Acute toxicity: dermal

Dermal toxicity (LD50) rabbit for 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate was examined at dose concentration of >5000 mg/kg of body weight.This value suggests that the chemical does not exhibit acute toxicity through the dermal route.

Justification for classification or non-classification

The LD 50 values for 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate suggest that the substance will not be classified in any of the acute toxicity categories as per the C & L criteria set by EU.